A biotech de­vel­op­ing a syn­thet­ic bi­ol­o­gy Covid-19 vac­cine comes up short in first da­ta read­out — and in­vestors are flee­ing

One of the biotechs bet­ting on its vac­cine plat­form prov­ing use­ful in the long-term fight against Covid-19 re­port­ed a new batch of da­ta Fri­day morn­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.